Opko Health, Inc. (NASDAQ:OPK) shares are trading higher Thursday after the company announced a $100 million share repurchase program. Opko said it expects to fund the repurchase program from existing ...

OPKO Health's stock is flying high but volatile. The Quant Rating was recently upgraded to Buy, but has been mostly rated Hold or Sell. The company's focus on niche markets and acquisitions poses ...

We recently compiled a list of the 10 Best Stocks Under $3 to Buy Now. In this article, we are going to take a look at where OPKO Health, Inc. (NASDAQ:OPK) stands against the other stocks under $3.

Entera Bio Ltd. ENTX and OPKO Health, Inc. OPK recently announced positive topline pharmacokinetic/pharmacodynamic (PK/PD) results from their ongoing collaborative ...

OPKO Health stock has bounced back since February but remains down over 11% since last year. OPK stock's rally in recent months has been supported by strong buying volume and positive earnings ...

Multinational biopharmaceutical company OPKO Health's (OPK) stock climbed nearly 13% in price last year when the company announced its plans to acquire ModeX Therapeutics. However, given the company's ...

Opko Health, Inc. OPK shares are trading higher Wednesday after the FDA approved NGENLA treatment for pediatric growth hormone deficiency, produced in partnership with Pfizer PFE. What To Know: The ...

OPKO Health, Inc. OPK is a diversified healthcare company that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing ...

The pharmaceutical and diagnostics specialist ran into some SEC-related controversy in 2018; now, it's a major player in the fight against COVID-19. To sum up, it's not a bad idea to pay attention to ...